ProShare Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $393K | Sell |
|
|||||
|
2025
Q1 | $631K | Sell |
|
|||||
|
2024
Q4 | $912K | Buy |
|
|||||
|
2024
Q3 | $779K | Buy |
|
|||||
|
2024
Q2 | $567K | Sell |
|
|||||
|
2024
Q1 | $858K | Buy |
|
|||||
|
2023
Q4 | $933K | Buy |
|
|||||
|
2023
Q3 | $671K | Buy |
|
|||||
|
2023
Q2 | $689K | Buy |
|
|||||
|
2023
Q1 | $576K | Sell |
|
|||||
|
2022
Q4 | $717K | Buy |
|
|||||
|
2022
Q3 | $563K | Buy |
|
|||||
|
2022
Q2 | $566K | Sell |
|
|||||
|
2022
Q1 | $741K | Sell |
|
|||||
|
2021
Q4 | $1.12M | Buy |
|
|||||
|
2021
Q3 | $866K | Sell |
|
|||||
|
2021
Q2 | $1.12M | Buy |
|
|||||
|
2021
Q1 | $1.04M | Buy |
|
|||||
|
2020
Q4 | $2.24M | Buy |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $1.14M | Buy |
|
|||||
|
2020
Q1 | $463K | Sell |
|
|||||
|
2019
Q4 | $875K | Sell |
|
|||||
|
2019
Q3 | $787K | Buy |
|
|||||
|
2019
Q2 | $1.15M | Sell |
|
|||||
|
2019
Q1 | $1.31M | Buy |
|
|||||
|
2018
Q4 | $805K | Sell |
|
|||||
|
2018
Q3 | $1.21M | Sell |
|
|||||
|
2018
Q2 | $1.63M | Sell |
|
|||||
|
2018
Q1 | $1.65M | Sell |
|
|||||
|
2017
Q4 | $1.65M | Buy |
|
|||||
|
2017
Q3 | $1.57M | Buy |
|
|||||
|
2017
Q2 | $866K | Sell |
|
|||||
|
2017
Q1 | $659K | Sell |
|
|||||
|
2016
Q4 | $581K | Buy |
|
|||||
|
2016
Q3 | $768K | Sell |
|
|||||
|
2016
Q2 | $601K | Buy |
|
|||||
|
2016
Q1 | $903K | Sell |
|
|||||
|
2015
Q4 | $1.14M | Buy |
|
|||||
|
2015
Q3 | $1.42M | Buy |
|
|||||
|
2015
Q2 | $1.26M | Buy |
|
|||||
|
2015
Q1 | $838K | Buy |
|
|||||
|
2014
Q4 | $513K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $64K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $85K | Buy |
|
|||||
|
2013
Q2 | $68K | Buy |
|